Better adherence with once-daily antiretroviral regimens: a meta-analysis
about
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviewsEfficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDSPerampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptabilityThe Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-AnalysisOutcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysisExtended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulationsDeterminants of patient adherence: a review of systematic reviews.Women, Aging, and HIV: Clinical Issues and Management Strategies.Nevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulation.Recent key advances in human immunodeficiency virus medicine and implications for ChinaSingle-Tablet Regimens in HIV TherapyAdherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United StatesRecent trends in early stage response to combination antiretroviral therapy in Australia.A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.Examining the link between patient satisfaction and adherence to HIV care: a structural equation modelAdherence to antiretroviral therapy in India: a systematic review and meta-analysis.Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation.The role of dolutegravir in the management of HIV infectionTreatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs.Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?HIV treatment and care among Italian inmates: a one-month point survey.Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era.Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in AsiaMeta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment RegimensEffectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.Pharmacotherapy of pediatric HIV infectionSocioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review.Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed peopleAntiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen.Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana.Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patientsImpact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysisTriple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infection.Patients' Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIVAssociation between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV
P2860
Q24197536-71334B98-1CC2-48C1-AA8F-309D8DDB1C98Q26783253-710A7A4C-BA68-40C1-BBB4-1CAC9BF0E2BEQ26796447-1940162D-4BBB-4A75-90AD-8A24424B4DF1Q26865049-4E057A28-1938-414B-AA3F-7C8EEEA3F4C6Q27021762-94C5915C-A4D8-4FBC-8FBD-E5CFBD930872Q27027410-DA0023B3-EE85-41B5-9BF9-34BF69B4C5EFQ30541800-7E6E6898-F964-49F8-BC8E-C456E53C08B1Q33730038-426BDE31-FA09-48D1-B13A-6F105414323BQ33850152-ECC10A44-AA0C-4B68-B13D-DB7AA0DD4A3BQ33933502-3FD568E1-C84C-4022-A4F2-87C8117D9343Q33939110-146CFCB6-5197-4832-8261-CBEBD7D70A6AQ34181784-4C94A67E-702C-42C5-B9EC-D1E32B6F9B0EQ34289433-8FD2BB2D-4586-43C2-9BAC-4461B055547DQ34380750-B0362394-0683-4271-A777-8BA5027A1C7CQ34469240-A52CA2DF-0CD4-49D2-BA39-050FD4E430B3Q34575619-F7261A5F-4EA5-4CB6-9F9E-E66EF56FCDCBQ34859146-FBAA5C97-C994-46FD-878F-1546E81CA659Q35111299-69DB50C3-81D6-4536-A4E8-E5D5A23285E4Q35121450-107BAD7E-E864-40C0-8E62-3D69AE350793Q35147189-61F052C4-F004-47B4-8FA3-6A492CD76D52Q35674849-32F0F2D5-4DBD-41FB-9982-40902EAA6D41Q35865208-DD2367A0-F4DC-441B-839E-C89EFD024A5DQ35959086-AC22BC24-3113-438F-93B6-757C35E4DACFQ36048423-42E14D7C-E000-410F-A90A-EEBA1B1E24F7Q36063912-9FBC4668-54EF-448E-9848-A094C9510023Q36206941-321FCA31-344E-48CF-8EDB-EA23B106F56EQ36267762-3250F713-EFBF-4E09-B816-DCEF1C9DB01EQ36301325-A9252524-BA5A-4E46-8E7C-7BA44AB752D9Q36331777-47118539-2C7A-48A0-A524-E0E204E0FC15Q36346957-CF7B5547-32BE-4D54-8B99-B7AD73BCA1BAQ36460056-0B0F6FDC-A018-48BF-92E1-E7006458B7BEQ36518993-DF725E39-B58A-4BD4-B30B-FF2073660526Q36617684-D1A7F4E4-F5C3-4973-AC74-25A192173A11Q36710065-B7AEC1FC-9498-4465-94FB-D827D7EF38E4Q36785804-89463031-3742-4682-90B0-40A9CB6B7423Q36813121-D7D53367-6E00-4960-88F3-5E067B957B76Q36891527-0AEBF061-F5C2-4A76-9F63-188CF3F69809Q36958229-0C2477E8-7A59-4837-A50F-5BB454D495BBQ37022939-80D5684E-EB2F-4806-A6DD-05D3CF021008Q37069682-B7C25BEF-2B96-440B-87F3-4112ECEF2868
P2860
Better adherence with once-daily antiretroviral regimens: a meta-analysis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Better adherence with once-daily antiretroviral regimens: a meta-analysis
@en
Better adherence with once-daily antiretroviral regimens: a meta-analysis.
@nl
type
label
Better adherence with once-daily antiretroviral regimens: a meta-analysis
@en
Better adherence with once-daily antiretroviral regimens: a meta-analysis.
@nl
prefLabel
Better adherence with once-daily antiretroviral regimens: a meta-analysis
@en
Better adherence with once-daily antiretroviral regimens: a meta-analysis.
@nl
P2860
P356
P1476
Better adherence with once-daily antiretroviral regimens: a meta-analysis
@en
P2093
Edward M Gardner
Renaud Verdon
P2860
P304
P356
10.1086/596482
P407
P577
2009-02-01T00:00:00Z